# DTMO Production Readiness Report

Assessment date: **2026-08-15**  
Software baseline: **16.0.0rc12 plus accepted post-RC13 and E8 repository enhancements**

## 1. Assessment conclusion

DTMO has completed its repository-controlled engineering baseline, accountable functional unified-console acceptance and the E8.1–E8.10 vulnerability/CTI repository workstream. The post-E8 candidate has also been externally deployed and extensively tested by the accountable owner in an approved production-equivalent staging environment.

The repository-side Phase 8.2–8.5 validation/acceptance contracts are complete. The project is now in external evidence completion and accountable Phase 8 acceptance.

**Current decision: NOT PRODUCTION READY.**

Mandatory progression remains:

1. complete and accept Phase 8 external evidence against one immutable staging identity;
2. complete Phase 9 independent external assurance;
3. complete Phase 10 formal production go/no-go.

## 2. Readiness summary

| Readiness dimension | Current position | Decision |
|---|---|---|
| Engineering / CI | Exact-head engineering baseline accepted | `PASS` |
| Functional product | Unified console owner-accepted | `PASS / OWNER_ACCEPTED` |
| E8 vulnerability/CTI scope | Repository-complete | `PASS / REPOSITORY_COMPLETE` |
| External staging deployment | Owner-verified and approved | `PASS / OWNER_VERIFIED_EXTERNAL_EVIDENCE` |
| Platform/identity validation contract | Repository-complete | `EXTERNAL ACCEPTANCE REQUIRED` |
| Source-to-intelligence contract | Repository-complete | `EXTERNAL ACCEPTANCE REQUIRED` |
| Operations/recovery contract | Repository-complete | `EXTERNAL ACCEPTANCE REQUIRED` |
| Accountable staging acceptance contract | Repository-complete | `EXTERNAL OWNER DECISION REQUIRED` |
| Independent assurance | Not complete | `PENDING` |
| Production approval | Not started | `BLOCKED_BY_PHASES_8_9` |

## 3. Product baseline

The accepted repository/product baseline includes:

- one canonical operator shell across Overview, Intelligence, Sources & Catalog, Visual Analytics, Administration and Governance;
- durable canonical intelligence and provenance;
- governed source registration/activation/execution;
- severity/classification semantics and filtering;
- native trend and vulnerability analytics;
- governed Administration/RBAC and privileged-action safeguards;
- versioned Governance framework knowledge and explicit evidence mappings;
- OpenCVE and CIRCL Vulnerability-Lookup;
- explainable vulnerability prioritization and vendor/product relevance;
- governed MISP read and separately approved outbound sharing;
- governed AIL read/enrichment/correlation;
- Normenkader IBP SM.07-oriented vulnerability-management evidence mapping with explicit semantic boundaries.

## 4. Security posture

### Identity and access

DTMO enforces server-side RBAC and least privilege, validates bearer-token trust, separates human and service principals, protects privileged Administration operations and maintains attributable audit/correlation evidence.

### Secrets and environment boundaries

Credentialed integrations use logical secret references and approved runtime resolution. Repository evidence must not contain raw secrets. Development/bootstrap identities and compatibility exceptions are not valid staging/production identity patterns.

### Publication and sharing authority

No connector, import, CI result, dashboard, Administration action, Governance mapping or staging access grants automatic publication authority. External sharing remains separately governed and human-approved.

## 5. Data architecture and integrity

- PostgreSQL: canonical application/intelligence/RBAC state;
- OpenSearch: search/index representation;
- S3-compatible object storage: raw evidence;
- Redis: coordination/cache/queue state;
- Prometheus/Grafana: operational observability.

Canonical persistence is the durable application boundary. Supporting stores and analytics do not replace the canonical record.

## 6. Governance and framework coverage

DTMO uses explicit, versioned and provenance-backed relationships. The current product includes governed relationships to Normenkader IBP, MITRE ATT&CK and NIST CSF and uses CVSS as vulnerability-scoring context. E8.10 adds repository-backed vulnerability/CTI evidence mapping, including Normenkader IBP SM.07 and supporting context.

These relationships do not imply full framework compliance, maturity, certification, local exposure, exploitability, compromise or completed remediation. Claims remain limited to the recorded mapping and evidence semantics.

## 7. Phase 8 assessment

### What is complete

- repository validation contracts for Phase 8.2 platform/identity;
- repository validation contract for Phase 8.3 source-to-intelligence;
- repository validation contract for Phase 8.4 operations/recovery/rollback;
- repository acceptance contract for Phase 8.5 accountable staging acceptance;
- owner-verified existence and successful testing of the post-E8 production-equivalent staging deployment.

### What remains

Formal Phase 8 closure requires a single reviewable external evidence package bound to one immutable staging deployment identity. It must include or reference:

- approved environment ID/owner/access path;
- exact deployed release/commit;
- immutable application/supporting image digests;
- runtime/infrastructure and configuration parity/deviation evidence;
- least-privilege IAM, service identities and secret-management references;
- TLS/network and controlled data/sanitization evidence;
- platform health, persistence, search/cache/storage and authorization validation;
- source retrieval through canonical intelligence presentation and traceability;
- operations, recovery, rollback and RTO/RPO observations;
- deployment/change/security/CVE review;
- approved residual risk/deviations;
- confirmation that no unresolved release-blocking staging finding remains;
- accountable Phase 8.5 `PASS / OWNER_ACCEPTED` or `BLOCKED` decision.

## 8. Phase 9 requirements

Independent external assurance is the next assurance stage after Phase 8 acceptance. Expected evidence classes include:

- independent penetration testing;
- hardening/configuration review;
- IAM/secrets-management review;
- representative production-equivalent load/stress validation;
- resilience/recovery review;
- monitoring/incident-response readiness review;
- relevant privacy/legal/governance review;
- assurance-time dependency/CVE review;
- severity-based finding triage, remediation and retest;
- residual-risk disposition and final independent assurance acceptance.

Internal CI or owner self-attestation cannot substitute for independent assurance.

## 9. Phase 10 decision requirements

Production go/no-go requires accepted Phase 8 and Phase 9 evidence plus accountable approval of production ownership/support, IAM/secrets/network controls, backup/recovery/rollback, monitoring/on-call/escalation, privacy/data/legal requirements, open findings/residual risk and the formal release/change decision.

## 10. Evidence boundaries

- Repository CI proves only repository-controlled engineering claims within test scope.
- Owner functional acceptance is an accountable product evidence class.
- Owner-verified staging deployment confirms the external environment/deployment fact but does not replace complete immutable evidence binding.
- Phase 8 external validation evidence must be attributable to the accepted staging candidate.
- Phase 9 must be independent.
- Phase 10 is a separate accountable production authorization.
- Historical run evidence is immutable and remains scoped to the state it actually covered.

## 11. Recommendation

Do not add unnecessary product scope to the current release candidate. Complete Phase 8 external evidence binding and accountable acceptance, then proceed to independent Phase 9 assurance. Do not designate DTMO production ready until Phase 10 records an explicit go decision.
